Related Experiment Videos
New therapies for cystic fibrosis
1Department of Pediatrics, Tulane University School of Medicine-New Orleans, USA.
Abstract:
In the decade since the gene responsible for cystic fibrosis (CF) was identified, our understanding of the pathophysiology of CF pulmonary disease has significantly improved. The current model for CF lung disease suggests several levels at which clinical interventions may be made in an attempt to alter the natural course of disease progression. The first part of this review highlights some of the progress made in novel forms of therapy directed at earlier portions of the pathophysiologic cascade such as gene therapy, protein therapy, and ion-transport regulatory therapy. New developments in well-established modes of therapy such as mucolytic therapy, airway clearance therapy, and antibiotic therapy are discussed next. The review concludes with a look at the use of two forms of therapy that have been adapted to CF care, anti-inflammatory therapy and lung transplantation.
Insights
Cystic Fibrosis (CF) research has advanced understanding of CF lung disease, leading to novel therapies. This review covers emerging and established treatments, including gene therapy and lung transplantation, to improve patient outcomes.
Area of Science:
- Pulmonary Medicine
- Medical Genetics
- Pharmacology
Background:
- Significant progress in understanding cystic fibrosis (CF) pathophysiology since gene identification.
- CF lung disease involves complex pathways offering multiple intervention points.
Purpose of the Study:
- To review advancements in CF pulmonary disease therapies.
- To highlight novel and established treatment strategies.
Main Methods:
- Review of current literature on CF therapeutic approaches.
- Categorization of therapies based on pathophysiologic targets and established practice.
Main Results:
- Novel therapies targeting early pathophysiologic cascade (gene, protein, ion-transport).
- Developments in established therapies (mucolytic, airway clearance, antibiotic).
- Adaptation of anti-inflammatory therapy and lung transplantation for CF care.
Conclusions:
- Multiple therapeutic avenues exist to alter CF lung disease progression.
- Ongoing research and adaptation of treatments offer improved patient management.
- Future directions include gene therapy, advanced supportive care, and transplantation.